POSTVACCINAL IMMUNITY TO HEPATITIS IN THE DONORS PLASMA

 

Immunology, microbiology, genetics

 

Abstract: 

The Donor immunoglobulin against hepatitis B in today's day is one of the main means of treatment and emergency prevention of viral hepatitis B in the number of drugs with interferon, etc. Prepare the necessary volume of blood plasma for the production of immunoglobulin, to increase the specific activity of the drug and at the same time rational use of donor contingent allows a new approach to the acquisition of groups of immune donors, namely — a focused selection of donors, from which it is supposed to active development of specific antibodies.

 

donors, immunity, vaccination, antibodies, hepatitis В.

 

Authors

Renyova Larisa V.

l.v.reneva@mail.ru

FSUC «Microgen» of the Ministry of Health of the Russian Federation in the city Perm, the Perm SPA «Biomed» 

 

Volkova Larisa V

wolkowalw@mail.ru

Perm State Technical University, the Department of chemistry and biotechnology, Russia; 

 

Kazyanin Alexander V.

Perm state pharmaceutical Academy, the Department of industrial technology of drugs with a course of biotechnology, Russia